Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Independent tests show Evion’s graphite is highly suitable for lithium batteries
Independent tests show Evion’s graphite is highly suitable for lithium batteries

Outstanding results support Evion’s strategy to develop downstream graphite processing business to supply battery anode makers

 

Key Points

 

-          Advanced testing by an independent

Nano One and Umicore Enter into Joint Development Agreement for Battery Materials Process Technology
Nano One and Umicore Enter into Joint Development Agreement for Battery Materials Process Technology

December 21, 2022, Vancouver, Canada (TSX: NANO) (OTC: NNOMF) (Frankfurt: LBMB)

 

-          Parties to jointly leverage their technologies for high nickel NMC cathode active materials.

-    

Trillium Gold Announces Results of Annual General and Special Meeting
Trillium Gold Announces Results of Annual General and Special Meeting

Vancouver, British Columbia, Canada – December 20, 2022 – Trillium Gold Mines Inc. (TSXV:TGM, OTCQX:TGLDF, FRA:0702) (“Trillium Gold” or the “Company” - https://www.commodity-tv.com/ondemand/

FRX Innovations Inc.: Investors with $8 trillion call to phase out 'forever chemicals' (PFAS)
FRX Innovations Inc.: Investors with $8 trillion call to phase out 'forever chemicals' (PFAS)

 

 

FRX Answers the Call - with proven and sustainable flame-retardant alternatives that are PFAS and Halogen free.

 

Boston, MA, December 20, 2022 - FRX Innovations (TSXV:FRXI) (FSE:W2A)

Breakthrough Results: Defence's Novel AccuTOX(TM) Intranasal Reduced 50% of Cancer Nodules on Animals with Lung Tumors
Breakthrough Results: Defence's Novel AccuTOX(TM) Intranasal Reduced 50% of Cancer Nodules on Animals with Lung Tumors

 

 

Vancouver, BC, Canada, December 20th, 2022 - Defence Therapeutics Inc. (“Defence” or the “Company”), a Canadian biopharmaceutical company specialized in the development of immune-oncology

Nicola Provides Year in Review: 2022
Nicola Provides Year in Review: 2022

December 20, 2022Nicola Mining Inc. (the “Company” or “Nicola”) “) (TSX.V: NIM, FWB: HLI, OTCBB: HUSIF) is providing “Year in Review: 2022”, with the hope that it provides additional

May Health Completes Treatment of Five Participants in U.S. Feasibility Study of its Ovarian Rebalancing Treatment for PCOS-related Infertility
May Health Completes Treatment of Five Participants in U.S. Feasibility Study of its Ovarian Rebalancing Treatment for PCOS-related Infertility

The targeted, one-time ovarian ablation procedure aims to induce ovulation for women seeking solutions for infertility related to the endocrine disorder polycystic ovary syndrome (PCOS)

 

TUGA Innovations Launches NFT Marketing Program
TUGA Innovations Launches NFT Marketing Program
News Release Comments (00018542.DOCX;1)

 

 

-          Company joins with BACD.IO for Sustainable Transportation Utility Token

-          Announces Dubai-Based Online Promotional Event

Y2 Solution Announces Plans for EV Fast-Charging Infrastructure Expansion in North America
Y2 Solution Announces Plans for EV Fast-Charging Infrastructure Expansion in North America

Dec-20-2022. Seoul, Korea & Chicago, USA: Y2 Solution (Listed KOSPI : 011690), today announced ambitious plans for the North American EV DC Fast-Charging market with the pre-release of its

Vizsla Silver Enters into Definitive Agreement for Strategic Investment in Prismo Metals
Vizsla Silver Enters into Definitive Agreement for Strategic Investment in Prismo Metals

 

 

Vancouver, British Columbia (December 19, 2022) - Vizsla Silver Corp. (TSX-V: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) (“Vizsla” or the “Company” - https://www.commodity-tv.com/ondemand/compan

Scryb Announces New Contract Win for Cybeats with Fortune 500 Industrial Technology Company
Scryb Announces New Contract Win for Cybeats with Fortune 500 Industrial Technology Company

 

 

TORONTO, December 19, 2022 - Scryb Inc. (“Scryb'' or the “Company”) (CSE: SCYB, OTCQB: SCYRF, Frankfurt: EIY), is pleased to report that Cybeats Technologies Corp. (“Cybeats”), a public

Alpha Lithium Achieves Best Grades To-Date at Tolillar Salar, Argentina
Alpha Lithium Achieves Best Grades To-Date at Tolillar Salar, Argentina

VANCOUVER, British Columbia, December 19, 2022 -- Alpha Lithium Corporation (NEO: ALLI) (OTC: APHLF) (German WKN: A3CUW1) (“Alpha” or the “Company” - https://www.commodity-tv.com/ondemand/co

Alpha Copper Completes Acquisition of CAVU Energy Metals
Alpha Copper Completes Acquisition of CAVU Energy Metals

VANCOUVER, British Columbia, December 19, 2022 – Alpha Copper Corp. (CSE: ALCU) (OTC: ALCUF) (FSE: PP0) (“Alpha”) and CAVU Energy Metals Corp. (CSE: CAVU) (OTC:CAVVF) (FSE: 5EO) (“CAVU”) are

Asante Gold Announces FY 2023 Q3 Results and Provides Operational Update
Asante Gold Announces FY 2023 Q3 Results and Provides Operational Update

Vancouver, British Columbia – December 19, 2022 – Asante Gold Corporation (“Asante” or the “Company” CSE:ASE | GSE:ASG | FRANKFURT:1A9 | U.S.OTC:ASGOF) today reported its operating and

Music Licensing, Inc. (OTC: SONG) Announces Major Updates for Investors: Form 211 Filing, Potential Forward Stock Split or Dividend, and Plans to List on Nasdaq
Music Licensing, Inc. (OTC: SONG) Announces Major Updates for Investors: Form 211 Filing, Potential Forward Stock Split or Dividend, and Plans to List on Nasdaq

NAPLES, FL / ACCESSWIRE / December 19, 2022 / Music Licensing, Inc. (OTC PINK:SONG), owner of Pro Music Rights, one of the world's largest music licensing companies, is pleased to announce

Jourdan Secures $4 Million Firm Commitment and $6 Million Option from North American Lithium to Explore Vallée Lithium Project
Jourdan Secures $4 Million Firm Commitment and $6 Million Option from North American Lithium to Explore Vallée Lithium Project

December 19, 2022 – Toronto (Canada) – JOURDAN RESOURCES INC. (TSXV: JOR; OTCQB: JORF; FRA:2JR1) (“Jourdan” or the “Company“) is pleased to announce that North American Lithium Inc. (“NAL”),

Uranium Energy Corp. Reports Quarterly Results for Period Ended October 31, 2022, Fiscal 2023 Q1
Uranium Energy Corp. Reports Quarterly Results for Period Ended October 31, 2022, Fiscal 2023 Q1

Completed two accretive acquisitions, realized profit from Physical Portfolio, and strengthened balance sheet:

 

-          Industry leading growth with two accretive acquisitions of UEX

XORTX Announces Completion of Dosing in XRX-OXY-101 Clinical Study
XORTX Announces Completion of Dosing in XRX-OXY-101 Clinical Study

CALGARY, AB – December 19, 2022 – XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on

Else Announces Investment for Gross Proceeds of Up to US$13.75M
Else Announces Investment for Gross Proceeds of Up to US$13.75M
News Release Announcing First Closing (00016645-12).DOCX

Vancouver, British Columbia, December 19, 2022 – ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the “Company”)

High Tide Opens New Canna Cabana Store In Suburban Ottawa
High Tide Opens New Canna Cabana Store In Suburban Ottawa

CALGARY, AB, December 19, 2022 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar

dynaCERT Announces Global Sales in 4th Quarter 2022
dynaCERT Announces Global Sales in 4th Quarter 2022

TORONTO, ON--( – December 19, 2022). dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce substantial upturn of its 4th Quarter 2022 sales,

 Antisense Therapeutics Limited: Clinical Trial Application submitted for ATL1102 Phase IIb DMD trial conduct in Europe
Antisense Therapeutics Limited: Clinical Trial Application submitted for ATL1102 Phase IIb DMD trial conduct in Europe
_ December 2008

 

19 December 2022 - Antisense Therapeutics Limited [ASX:ANP | US OTC:ATHJY | FSE:AWY] (ANP or Company) today announced that it has now submitted a Clinical Trial Application

First Hydrogen Expands Its Design of Zero-Emission Vehicles
First Hydrogen Expands Its Design of Zero-Emission Vehicles

Vancouver, B.C., December 19, 2022 Vancouver, British Columbia First Hydrogen Corp. (“FIRST HYDROGEN” or the “Company”) (TSXV: FHYD) (OTC: FHYDF) (FSE: FIT) is pleased to announce it has